Forum » General » News and Announcements » Flexicon Liquid Filling launches new vial fill system

Flexicon Liquid Filling launches new vial fill system

  • 1 3314
    The chances of meeting each person may be different.รีวิวเว็บตรงสล็อตออนไลน์น่าเชื่อถือ นี่คือเว็บไซต์ Asia999 ที่มีเกมส์สล็อตออนไลน์มากที่สุดในประเทศไทย ฝากถอนง่ายเว็บตรงสล็อต
      June 1, 2023 5:52 PM MDT
    0
  • British aseptic finish experts Flexicon Liquid Filling have launched Cellefill, a turnkey, vial fill system with an integrated barrier solution.Get more news about Aseptic Liquid Filling Machine,you can vist our website!

    Cellefill integrates the features of Flexicon's FPC60 aseptic vial filling machine with barrier technologies from Franz Ziel. Cellefill's process design includes use of asepticsu single-use-systems (SUS) and pre-sterilised ready to use (RTU) product containers that enter the Grade A filling zone by a No Touch Transfer (NTT) debagging system.

    The solution is also GMP compliant and delivers enhanced levels of process flexibility to accelerate production of ATMPs and biological therapies.Flexicon is a brand of Watson-Marlow Fluid Technology Solutions (WMFTS) and barrier technology specialists Franz Ziel GmbH.

    Designed to suit various filling requirements and class cleanrooms, the Cellefill solution is available in three models with different barrier technologies. Each model delivers enhanced levels of process and quality assurance with highly accurate peristaltic pump performance, integrated barrier and environmental monitoring.

    Steve Adams, Product Manager for Cellefill at WMFTS, said: "Through process flexibility, Cellefill enables the scale out and process repeatability our customers need to assure product quality at all levels of manufacturing. Providing expert guidance and support through a single point of contact, we are a committed project partner to biopharmaceutical companies at the cutting-edge of personalised medicine.

    Cellefill builds on the partner's experience in providing technology and extensive support through validation, qualification and operator training to facilitate a smooth transition into GMP compliant and cost-effective manufacturing.

    Adams added: "The challenge for the industry is to produce these new therapies quickly, safely and cost efficiently, with a system that can be rapidly changed between batch or different small batch medicines."

      May 29, 2023 1:12 AM MDT
    0